Sign in

You're signed outSign in or to get full access.

Teladoc Health (TDOC)

--

Earnings summaries and quarterly performance for Teladoc Health.

Research analysts who have asked questions during Teladoc Health earnings calls.

Jailendra Singh

Jailendra Singh

Truist Securities

7 questions for TDOC

Also covers: ACCD, AGL, AMWL +16 more
Jessica Tassan

Jessica Tassan

Piper Sandler

7 questions for TDOC

Also covers: ACCD, ALHC, AMWL +12 more
Richard Close

Richard Close

Canaccord Genuity Group

6 questions for TDOC

Also covers: ACCD, AHCO, CLOV +15 more
CR

Charles Rhyee

TD Cowen

5 questions for TDOC

Also covers: AMWL, BTSG, CAH +20 more
Daniel Grosslight

Daniel Grosslight

Citigroup

5 questions for TDOC

Also covers: ACH, AGL, CAH +13 more
DR

David Roman

Goldman Sachs Group Inc.

5 questions for TDOC

Also covers: ABT, BAX, BBNX +21 more
Sarah James

Sarah James

Cantor Fitzgerald

5 questions for TDOC

Also covers: ACHC, AMED, ARDT +16 more
Sean Dodge

Sean Dodge

RBC Capital Markets

5 questions for TDOC

Also covers: BTSG, CDMO, CTLT +15 more
Allen Lutz

Allen Lutz

Bank of America

4 questions for TDOC

Also covers: ACCD, CAH, COR +15 more
LG

Lisa Gill

JPMorgan Chase & Co.

4 questions for TDOC

Also covers: AGL, CAH, CI +15 more
Elizabeth Anderson

Elizabeth Anderson

Evercore ISI

3 questions for TDOC

Also covers: AGL, ALGN, CAH +24 more
George Hill

George Hill

Deutsche Bank

3 questions for TDOC

Also covers: AGL, CAH, CI +16 more
Michael Cherny

Michael Cherny

Leerink Partners

3 questions for TDOC

Also covers: ACCD, ACH, AKBA +23 more
AV

Ayush Vyas

Evercore ISI

2 questions for TDOC

Brian Tanquilut

Brian Tanquilut

Jefferies

2 questions for TDOC

Also covers: ACHC, ADUS, AHCO +31 more
GS

Glen Santangelo

Jefferies

2 questions for TDOC

Also covers: ALGN, ANIP, BHC +16 more
JG

Jeff Garro

Stephens

2 questions for TDOC

Also covers: CERT, DH, DOCS +6 more
Ryan MacDonald

Ryan MacDonald

Needham & Company

2 questions for TDOC

Also covers: ACCD, AMWL, BNED +21 more
SB

Stan Berenshteyn

Wells Fargo Securities

2 questions for TDOC

Also covers: AMWL, DOCS, GDRX +5 more
SD

Stephanie Davis

Barclays

2 questions for TDOC

Also covers: ACCD, CAH, COR +20 more
SP

Sameer Patel

Evercore Inc.

1 question for TDOC

Also covers: HCAT, PDCO, PRVA

Recent press releases and 8-K filings for TDOC.

Teladoc Health Reports Q4 2025 Results and Provides 2026 Guidance
TDOC
Earnings
Guidance Update
New Projects/Investments
  • Teladoc Health reported full-year 2025 BetterHelp revenue of $950 million, a 9% decline from the prior year, with an adjusted EBITDA of $42 million.
  • For full-year 2026, the company expects consolidated revenue between $2.47 billion and $2.59 billion and adjusted EBITDA between $266 million and $308 million, representing a 2% year-over-year growth at the midpoint for EBITDA.
  • The Integrated Care segment is projected to grow revenue by 0.4%-3.9% in 2026, while the BetterHelp segment revenue is guided to decline by 7% to 0.5%. BetterHelp's insurance offering is expected to generate $75 million to $90 million in revenue in 2026, with an annualized run rate of over $100 million by year-end.
  • Strategic priorities for 2026 include advancing the U.S. integrated care segment through product innovation and AI-enabled capabilities, and scaling the BetterHelp insurance offering to mitigate direct-to-consumer cash pay headwinds.
Feb 25, 2026, 10:00 PM
Teladoc Health Announces Q4 2025 Results and FY 2026 Outlook
TDOC
Earnings
Guidance Update
Demand Weakening
  • Teladoc Health reported Q4 2025 revenue of $642 million and an Adjusted EBITDA of $83.8 million, marking a 12% year-over-year increase. The net loss per share for Q4 2025 was $(0.14).
  • The company provided FY 2026 revenue outlook ranging from $2,470 million to $2,587 million and Adjusted EBITDA outlook between $266 million and $308 million.
  • For Q1 2026, Teladoc Health expects revenue between $598 million and $620 million and Adjusted EBITDA from $50 million to $62 million.
  • As of December 31, 2025, cash and cash equivalents were $781 million, with operating cash flow of $88 million and free cash flow of $53 million for Q4 2025.
Feb 25, 2026, 10:00 PM
Teladoc Health Announces Q4 and Full-Year 2025 Results and Provides 2026 Guidance
TDOC
Earnings
Guidance Update
Demand Weakening
  • Teladoc Health reported Q4 2025 consolidated revenue of $642 million and full-year 2025 consolidated revenue of $2.53 billion, a 1.5% decline from the prior year. Full-year adjusted EBITDA was $281 million, with a net loss per share of $1.14.
  • For the full year 2025, Integrated Care segment revenue increased 3.3% to $1.58 billion, while BetterHelp segment revenue declined 9% to $950 million. BetterHelp's Q4 adjusted EBITDA significantly improved to $18 million from $4 million in the third quarter.
  • The company projects full-year 2026 consolidated revenue to be in the range of $2.47 billion-$2.59 billion and consolidated adjusted EBITDA between $266 million-$308 million. Full-year free cash flow is expected to be $130 million-$170 million.
  • BetterHelp's insurance offering is anticipated to generate $75 million-$90 million in revenue in 2026, with an annualized revenue run rate exceeding $100 million by year-end. U.S. integrated care members are expected to end 2026 in the range of 97 million-100 million, a modest decrease from 2025 levels.
Feb 25, 2026, 10:00 PM
Teladoc Health Reports Q4 and Full-Year 2025 Results, Provides 2026 Guidance
TDOC
Earnings
Guidance Update
New Projects/Investments
  • Teladoc Health reported Q4 2025 consolidated revenue of $642 million and full-year 2025 consolidated revenue of $2.53 billion, a 1.5% decrease from the prior year. Full-year adjusted EBITDA was $281 million, representing an 11.1% margin.
  • The Integrated Care segment grew 4.7% in Q4 2025 to $409 million and 3.3% for the full year to $1.58 billion, while BetterHelp revenue declined 6.7% in Q4 to $233 million and 9% for the full year to $950 million.
  • For 2026, Teladoc guides BetterHelp revenue to decline 0.5% to 7% year-over-year, but expects $75 million to $90 million in insurance-based revenue from BetterHelp, with an annualized run rate exceeding $100 million by year-end.
  • The company ended 2025 with $781 million in cash after retiring $550 million in convertible debt and plans to address the remaining 2027 convertible notes through a combination of cash and new term loan debt.
Feb 25, 2026, 10:00 PM
Teladoc Health Reports Fourth Quarter and Full Year 2025 Results
TDOC
Earnings
Guidance Update
Demand Weakening
  • Teladoc Health reported Fourth Quarter 2025 revenue of $642.3 million, which was flat year-over-year, and Full Year 2025 revenue of $2,530.0 million, down 2% year-over-year. The company posted a net loss of $25.1 million ($0.14 per share) for Q4 2025 and a net loss of $200.3 million ($1.14 per share) for Full Year 2025.
  • Adjusted EBITDA for Q4 2025 was $83.8 million, up 12% year-over-year, while Full Year 2025 Adjusted EBITDA was $281.1 million, down 10% year-over-year.
  • For Full Year 2025, operating cash flow was $294.4 million (flat year-over-year) and free cash flow was $166.9 million (down 2% year-over-year), with $781.1 million in cash and cash equivalents at year-end.
  • The Integrated Care segment revenue increased 5% to $409.1 million in Q4 2025, while the BetterHelp segment revenue decreased 7% to $233.2 million.
  • For Full Year 2026, Teladoc Health expects revenue between $2,470 million and $2,587 million, Adjusted EBITDA between $266 million and $308 million, and a net loss per share between ($1.10) and ($0.70).
Feb 25, 2026, 9:04 PM
Teladoc Health Outlines 2026 Strategic Priorities and Product Innovations
TDOC
Product Launch
New Projects/Investments
Demand Weakening
  • Teladoc Health is actively transitioning its BetterHelp segment into the insurance-covered benefit space, expanding from 12 states plus DC with plans for a broader national rollout throughout 2026, to address cost as a primary barrier for user conversion and retention.
  • The company is launching new products and enhancements for 2026 across its Integrated Care business, including a new 24/7 offering to expand service scope and integrate specialties, new AI-enabled chronic care features, and expanded hybrid care models internationally.
  • Teladoc has seen a significant migration from subscription-based to visit-based revenue models, with over 50% of its virtual care revenues in 2025 now coming from visit-based arrangements, which has created some gross margin pressure being offset by cost reductions.
  • Teladoc added 8.5 million members in 2025, bringing its total platform membership to 103 million, representing a 10% growth over 2024.
  • The company extensively utilizes Artificial Intelligence (AI) across its operations, from BetterHelp's intake process and clinician support to device data analysis in acute care settings, with further proliferation expected in 2026.
Jan 12, 2026, 11:45 PM
Teladoc Health Discusses Q3 2025 Performance and 2026 Strategic Priorities
TDOC
Product Launch
New Projects/Investments
  • Teladoc Health reported $2.5 billion in revenues and over $270 million in Adjusted EBITDA on a trailing 12-month basis as of the third quarter of 2025. The company maintained a strong financial position with over $700 million in cash at the end of Q3 2025, after paying off $500 million of converts.
  • The company is focused on product innovation for 2026, including the launch of a new 24/7 virtual care offering and new AI-enabled models for chronic care. They are also expanding their BetterHelp insurance model, which covered 12 states plus D.C. by year-end 2025 and is expected to provide access to over 120 million people once scaled, with continued rollout throughout 2026.
  • Teladoc noted a shift in its virtual care business, with over 50% of 2025 revenues coming from visit-based arrangements, a change from subscription models that can pressure gross margins but is being mitigated by cost reductions. The company anticipates 2026 to be an "execution year" with both headwinds and tailwinds.
Jan 12, 2026, 11:45 PM
Teladoc Health Presents Strong Financials and Strategic Priorities at J.P. Morgan Healthcare Conference
TDOC
Earnings
New Projects/Investments
M&A
  • Teladoc Health reported $2.5 billion in revenue and $272 million in Adjusted EBITDA for the trailing 12 months as of September 30, 2025.
  • The company's Integrated Care segment generated $1.6 billion in revenue and $227 million in Adjusted EBITDA, while the BetterHelp segment contributed $1.0 billion in revenue and $45 million in Adjusted EBITDA for the same period.
  • In 2025, Teladoc Health advanced key initiatives including the acquisition of Catapult Health and UpLift, delivering double-digit organic revenue growth in Integrated Care International, and rolling out localized models in non-U.S. markets for mental health.
  • For 2026, the company plans to deepen market penetration and extend to new geographies for Integrated Care, and scale provider capacity and expand in-network insurance coverage for BetterHelp.
  • Teladoc Health maintains a strong financial position with $726 million in cash and cash equivalents, a net-debt to TTM Adjusted EBITDA of ~1.0X, and $170 million in Free Cash Flow as of September 30, 2025.
Jan 12, 2026, 11:45 PM
Teladoc Health provides business update at J.P. Morgan Healthcare Conference
TDOC
Product Launch
New Projects/Investments
M&A
  • Teladoc Health reported $2.5 billion in revenues and over $270 million in Adjusted EBITDA on a trailing 12-month basis as of the third quarter of 2025.
  • The company is strategically moving its BetterHelp segment into the insurance-covered benefit space to improve user conversion and retention, with coverage currently in 12 states plus DC.
  • Teladoc added 8.5 million members in 2025, bringing its total platform membership to 103 million people, a 10% increase over 2024.
  • More than 50% of virtual care revenues in 2025 now come from visit-based arrangements, a shift from subscription models, which can impact gross margins but is being offset by cost-cutting.
  • Recent acquisitions include Catapult Health for preventative care and Telecare to expand its position in the Australia market, aligning with strategic priorities.
Jan 12, 2026, 11:45 PM
TadHealth Awarded San Diego County Education Contract
TDOC
New Projects/Investments
Revenue Acceleration/Inflection
  • TadHealth has been selected by the San Diego County Office of Education (SDCOE) to provide a county-wide Student Electronic Health Record (EHR) system.
  • This partnership supports California’s Children and Youth Behavioral Health Initiative (CYBHI), enabling participating school districts in San Diego County to begin billing for eligible services starting January 2026.
  • The contract positions TadHealth as the student EHR solution for San Diego County, serving over 500,000 students across 42 school districts.
  • TadHealth's platform facilitates CYBHI reimbursements, streamlining mental health services and unlocking funds for schools, as demonstrated by Anaheim Elementary School District receiving over $800K.
Dec 17, 2025, 1:00 PM